Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avijit Banik

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Neuroinflammation|November 21, 2021
Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's diseaseAvijit Banik, Radhika Amaradhi, Daniel Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2022
Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal modelsVarun Rawat, Avijit Banik, Radhika Amaradhi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 7, 2021
A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in RatsAsheebo Rojas, Radhika Amaradhi, Avijit Banik, et al.
ACS Pharmacology & Translational Science|January 19, 2023
Temporal Expression of Neuroinflammatory and Oxidative Stress Markers and Prostaglandin E2 Receptor EP2 Antagonist Effect in a Rat Model of EpileptogenesisVarun Rawat, Clifford L Eastman, Radhika Amaradhi, et al.
Journal of Medicinal Chemistry|January 7, 2020
Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease ModelsRadhika Amaradhi, Avijit Banik, Shabber Mohammed, et al.
Scientific Reports|September 25, 2020
High glucose alters the DNA methylation pattern of neurodevelopment associated genes in human neural progenitor cells in vitroDeepika Kandilya, Sukanya Shyamasundar, Dhiraj Kumar Singh, et al.
Neuropharmacology|December 2, 2022
Preclinical development of an EP2 antagonist for post-seizure cognitive deficitsNicholas H Varvel, Radhika Amaradhi, Claudia Espinosa-Garcia, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?Avijit Banik, Richard E Brown, James Bamburg, et al.
Annals of Neurosciences|January 25, 2020
Creating a role model for "Academicians" Social Responsibility (ASR) synergizing with Swachh Bharat Abhiyaan: A campus hygiene initiative by PGIMER, ChandigarhAkshay Anand, Avijit Banik, Gillipsie Minhas, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Neuroinflammation|November 21, 2021
Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's diseaseAvijit Banik, Radhika Amaradhi, Daniel Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2022
Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal modelsVarun Rawat, Avijit Banik, Radhika Amaradhi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 7, 2021
A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in RatsAsheebo Rojas, Radhika Amaradhi, Avijit Banik, et al.
ACS Pharmacology & Translational Science|January 19, 2023
Temporal Expression of Neuroinflammatory and Oxidative Stress Markers and Prostaglandin E2 Receptor EP2 Antagonist Effect in a Rat Model of EpileptogenesisVarun Rawat, Clifford L Eastman, Radhika Amaradhi, et al.
Journal of Medicinal Chemistry|January 7, 2020
Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease ModelsRadhika Amaradhi, Avijit Banik, Shabber Mohammed, et al.
Scientific Reports|September 25, 2020
High glucose alters the DNA methylation pattern of neurodevelopment associated genes in human neural progenitor cells in vitroDeepika Kandilya, Sukanya Shyamasundar, Dhiraj Kumar Singh, et al.
Neuropharmacology|December 2, 2022
Preclinical development of an EP2 antagonist for post-seizure cognitive deficitsNicholas H Varvel, Radhika Amaradhi, Claudia Espinosa-Garcia, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?Avijit Banik, Richard E Brown, James Bamburg, et al.
Annals of Neurosciences|January 25, 2020
Creating a role model for "Academicians" Social Responsibility (ASR) synergizing with Swachh Bharat Abhiyaan: A campus hygiene initiative by PGIMER, ChandigarhAkshay Anand, Avijit Banik, Gillipsie Minhas, et al.
Pageof 3